Zobrazeno 1 - 10 of 11 pro vyhledávání: '"D C, Harmon"'
1
Akademický článek
Thromboembolic Events Associated with Thalidomide and Multimodality Therapy for Soft Tissue Sarcomas: Results of RTOG 0330
Autor: J. M. Kane, J. Harris, W. G. Kraybill, D. C. Harmon, D. S. Ettinger, D. R. Lucas, T. F. DeLaney, D. Wang, W. J. Curran, B. L. Eisenberg
Publikováno v: Sarcoma, Vol 2012 (2012)
Introduction. RTOG 0330 was developed to address the toxicity of RTOG 9514 and to add thalidomide (THAL) to MAID chemoradiation for intermediate/high grade soft tissue sarcomas (STSs) and to preoperative radiation (XRT) for low-grade STS. Methods. Pr
Externí odkaz: https://doaj.org/article/572eeb29097645c98d58a5f8ca138a53
Zobrazit plný text záznamu
3
S100beta and nitric oxide product concentrations following cerebral aneurysm clipping in patients with subarachnoid haemorrhage: a pilot study
Autor: K A, Ghori, D C, Harmon, A, Elashaal, F, Walsh, M G, O'sullivan, G D, Shorten
Publikováno v: Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine. 7(4)
The objective of this investigation was to determine the efficacy of S100beta and nitric oxide product (nitrate and nitrite [NOx]) concentrations as markers of brain injury following cerebral aneurysm clipping in patients with spontaneous subarachnoi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a6a67e58640e5d2ebbf4a87d2c6fe5be
https://pubmed.ncbi.nlm.nih.gov/16539584
Zobrazit plný text záznamu
5
A staff dialogue on aggressive palliative treatment demanded by a terminally ill patient: psychosocial issues faced by patients, their families, and caregivers
Autor: K C, Lintz, R T, Penson, N, Cassem, D C, Harmon, B A, Chabner, T J, Lynch
Publikováno v: The oncologist. 4(1)
Shortly before his death in 1995, Kenneth B. Schwartz, a cancer patient at Massachusetts General Hospital (MGH), founded The Kenneth B. Schwartz Center at MGH. The Schwartz Center is a nonprofit organization dedicated to supporting and advancing comp
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6ef60e57cb7ad32b713b6db431c47285
https://pubmed.ncbi.nlm.nih.gov/10337374
Zobrazit plný text záznamu
6
Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B
Autor: B L, Samuels, J E, Herndon, D C, Harmon, R, Carey, J, Aisner, J M, Corson, Y, Suzuki, M R, Green, N J, Vogelzang
Publikováno v: Cancer. 82(8)
In a prior Cancer and Leukemia Group B (CALGB) Phase II trial of patients with advanced, previously untreated mesothelioma, dihydro-5-azacytidine (DHAC) demonstrated a 17% response rate, including 1 complete response, with only mild myelosuppression.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::02378e76fb7db44806434225a6a0f143
https://pubmed.ncbi.nlm.nih.gov/9554537
Zobrazit plný text záznamu
7
Prognostic factors for local control of sarcomas of the soft tissues managed by radiation and surgery
Autor: I J, Spiro, M C, Gebhardt, L C, Jennings, H J, Mankin, D C, Harmon, H D, Suit
Publikováno v: Seminars in oncology. 24(5)
During the past decade, local control of primary sarcomas of the extremities by radiation and conservative surgery has supplanted more radical compartmental resections or amputations. Reviews of others and our published data show that the probability
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2c09059d29785e3f7d214be4138382c8
https://pubmed.ncbi.nlm.nih.gov/9344320
Zobrazit plný text záznamu
8
Dihydro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity. Cancer and Leukemia Group B
Autor: N J, Yogelzang, J E, Herndon, C, Cirrincione, D C, Harmon, K H, Antman, J M, Corson, Y, Suzuki, M L, Citron, M R, Green
Publikováno v: Cancer. 79(11)
Malignant mesothelioma is a disease that is refractory to chemotherapy. Therefore, the objective of this multi-institutional, cooperative group Phase II trial was to determine the efficacy of dihydro-5-azacytidine (DHAC), a pyrimidine analogue, in th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8be86311450cd5826ec6f81711b20728
https://pubmed.ncbi.nlm.nih.gov/9179072
Zobrazit plný text záznamu
9
Primary lymphoma of bone. A B-cell neoplasm with a high frequency of multilobated cells
Autor: C K, Pettit, L R, Zukerberg, M H, Gray, J A, Ferry, A E, Rosenberg, D C, Harmon, N L, Harris
Publikováno v: The American journal of surgical pathology. 14(4)
Primary lymphoma of bone is an uncommon neoplasm that can be difficult to diagnose and subclassify. Only in a few cases has the immunophenotype been determined with monoclonal antibodies. We evaluated the histological features and immunophenotype of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::346be30cea3b79507a0e256748cf49f6
https://pubmed.ncbi.nlm.nih.gov/2321697
Zobrazit plný text záznamu
10
Immunohistologic features predict clinical behavior of orbital and conjunctival lymphoid infiltrates
Autor: L J, Medeiros, D C, Harmon, R M, Linggood, N L, Harris
Publikováno v: Blood. 74:2121-2129
The natural history of lymphoid infiltrates of the orbit and conjunctiva is poorly understood. To determine if immunohistologic features could predict clinical outcome, these features were evaluated in 61 patients with orbital and conjunctival lympho
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35b1b918e330163c9d4ef49f1778a066
https://doi.org/10.1182/blood.v74.6.2121.bloodjournal7462121
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje